Tightening Schlemm's canal reduces IOP

Article

Tensioning of Schlemm's canal may reduce intraocular pressure (IOP) in non-penetrating surgical treatment of open angle glaucoma (OAG), according to the results of a study conducted by Manfred Tetz and colleagues from Germany.

Tensioning of Schlemm's canal may reduce intraocular pressure (IOP) in non-penetrating surgical treatment of open angle glaucoma (OAG), according to the results of a study conducted by Manfred Tetz and colleagues from Germany.

During a multicentre clinical study at four European and six US outpatient surgical centres, Schlemm's canal was exposed by surgical dissection during viscocanalostomy of 92 eyes. A flexible microcannula was inserted and advanced along the circumference to viscodilate the canal. Then a 10-0 prolene suture was tied to the tip of the microcannula and retracted into the canal and the suture ends were tied to apply tension to the inner wall and the trabecular meshwork. In 33 patients, the trabecular meshwork distension was measured using high resolution ultrasound imaging and correlated to IOP at one, three and six months postoperatively.

Average preoperative IOP was recorded at 27.8 mmHg on 2.0 medications. Six months postoperatively, 19 eyes with low suture tension had an average IOP of 15.0 mmHg on 0.13 medications as compared with 14 eyes with high suture tension whose average IOP was 13.6 mmHg on 0.10 medications.

The authors concluded that there is a correlation between reduced postoperative IOP and increased tension and that by tensioning Schlemm's canal it may be possible to reduce IOP in non-penetrating surgical treatment of OAG.

Ophthalmology Times Europe reporting from the XXIV Congress of the ESCRS, London, 9-13 September, 2006.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.